16-Feb-24 |
Buy |
Penelope Ruth Judd |
125.00p | 39,995 |
£49,993.75 |
28-Jul-23 |
Sell |
Gavin Jones |
118.00p | 68,882 |
£81,280.76 |
28-Jul-23 |
Exercise of option |
Gavin Jones |
0.000p | 146,044 |
£0.00 |
28-Jul-23 |
Sell |
Gavin Jones |
118.00p | 68,882 |
£81,280.76 |
16-Feb-24 |
Buy |
Penelope Ruth Judd |
125.00p | 39,995 |
£49,993.75 |
28-Jul-23 |
Exercise of option |
Gavin Jones |
0.000p | 146,044 |
£0.00 |
Geoffrey Rowley |
9,454,663 |
£11,581,962 |
Jeremy French |
6,050,984 |
£7,412,455 |
Gavin Jones |
145,343 |
£178,045 |
David Chubb |
68,750 |
£84,219 |
Penelope Ruth Judd |
39,995 |
£48,994 |
JTC plc |
250,932,590 |
£307,392,423 |
The EBT |
22,531,865 |
£27,601,535 |
Royal Bank of Canada |
18,750,000 |
£22,968,750 |
Liontrust Investment Management Limited |
17,550,000 |
£21,498,750 |
Gresham House Asset Management Ltd |
13,545,612 |
£16,593,375 |
Premier Miton Investors |
11,435,997 |
£14,009,096 |
|
3rd Interim |
2nd Interim |
Ex-Div |
16-May-24 |
22-Feb-24 |
Paid |
14-Jun-24 |
22-Mar-24 |
Amount |
0.90p |
0.90p |
CEO |
Geoffrey Rowley |
COO |
Jeremy French |
CFO |
Gavin Jones |
Top of Page
You are here:
research